Crossmark

Improving outcomes of patients with advanced prostate cancer through a better understanding of clinical factors contributing to financial toxicity: a qualitative study

Crossref DOI link: https://doi.org/10.1007/s00520-026-10384-9

Published Online: 2026-02-02

Published Print: 2026-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Olunuga, Ebunoluwa

Kurnot, Jeremy

Zhu, Samantha

George, Daniel J.

Docherty, Sharron L.

Kaye, Deborah R.
License Information

Text and Data Mining valid from 2026-02-01

Version of Record valid from 2026-02-01
More Information

Article History

Received: 30 May 2025

Accepted: 22 January 2026

First Online: 2 February 2026

Declarations

:

: The study was approved by the Duke University Institutional Review Board. Informed consent was obtained by all study participants. The study was conducted in accordance with the Helsinki Declaration as revised in 2013 and its later amendments.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below